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Indole-based perenosins as highly 
potent HCl transporters and 
potential anti-cancer agents
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Prodigiosin is one of the most potent anion transporters in lipid bilayer membranes reported to date. 
Inspired by the structure of this natural product, we have recently designed and synthesised a new class 
of H+/Cl− cotransporters named ‘perenosins’. Here we report a new library of indole-based perenosins 
and their anion transport properties. The new transporters demonstrated superior transmembrane 
transport efficiency when compared to other indole-based transporters, due to favourable 
encapsulating effects from the substituents on the perenosin backbone. Anion transport assays were 
used to determine the mechanism of chloride transport revealing that the compounds function as 
‘strict’ HCl cotransporters. Cell viability studies showed that some compounds specifically trigger late-
onset cell death after 72 h with a unique correlation to the position of alkyl chains on the perenosins. 
Further investigations of cell death mechanism showed a mixture of cell cycle arrest and apoptosis was 
responsible for the observed decrease in cell viability.
Synthetic transmembrane anion transporters are an area of intense current interest due to their potential appli-
cation in the treatment of diseases1–3. The potential for anti-cancer activity4, and to replace the anion transport 
process in patients with genetically impaired ion channels5, has led to a significant rise in the number of small 
molecule anion transporters developed, such as indole-based receptors6, the ortho-phenylenediamine-based 
bisureas7, as well as many others8–12. However, the natural product prodigiosin (Fig. 1) remains a benchmark for 
new anion transporters due to its potent anion transport properties in lipid bilayer membranes13–16. Prodigiosin 
has been shown to bind H+/Cl− through a combination of hydrogen bonds and electrostatic interactions17, allow-
ing it to facilitate H+/Cl− symport through membranes resulting in pH dissipation in both model liposomal and 
cell assays18–21. In cells, the dysregulation of ion homeostasis through chloride influx, which can be facilitated 
by anion transporters22, can induce cell shrinkage and leads to the apoptotic cell death pathway23–26. Another 
consequence of the dysregulation of intracellular chloride concentrations is disruption of autophagy, through the 
interruption of lysosomal enzyme activity caused by altering the lysosomal pH27. The disruption of autophagy by 
small molecule anion transporters results in the suppression of cell proliferation which is more pronounced in 
tumour cells28. A second family of recognised H+/Cl− cotransporters, the tambjamines29–31, have also been shown 
to induce lysosomal dysfunction29 and autophagy blockage32 as well as cancer cell death3.
The encouraging antitumor activity displayed by members of the prodiginines family33 has promoted the 
development of new synthetic derivatives such as obatoclax34. Recently, we have developed a new class of anion 
transporters, the “perenosins”, with structures inspired by that of prodigiosin (Fig. 1)35. The incorporation of an 
imine linker in the structural design of perenosins is beneficial for further pharmacokinetic studies, especially the 
metabolic breakdown pathway after administration.
Perenosins consist of a dimethylpyrrole unit linked through an imine moiety to an indole, benzimidazole 
or indazole heterocyclic functional group, which are the basis of other anion receptor systems36, 37. Perenosins 
function as H+/Cl− cotransporters in a similar fashion to prodigiosin, as protonation of the imine nitrogen leads 
to binding of the chloride anion. Liposome-based anion transport studies showed that the indole derivatives such 
as compound 1d (Fig. 2) performed as one of the more effective transporters, with superior cytotoxic properties 
among the initial compounds studied.
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Encouraged by the outstanding transmembrane transport and cytotoxic properties of compound 1d, we have 
developed a new family of perenosins 2–6 based on the indole-pyrrole scaffold of 1a–e, and bis-indole perenosins 
7–8. Here, we report detailed studies of the chloride anion binding, pKa in aqueous and lipid bilayer environ-
ments and transmembrane transport capabilities (and mechanisms) of the indole-based perenosins. We have 
also performed in-depth cell studies of the cytotoxic properties of these compounds (1a–e and 2–8), and have 
comprehensively elucidated the transport mechanism in liposomes as well as the cell death pathway induced by 
perenosins for the first time.
Results and Discussion
Indole-Based Perenosins. Design and synthesis. The pyrrole-indole derivatives of the first generation of 
perenosins featured modifications at one site, R1 (Fig. 1). Adapting the reported stepwise synthetic approach 
allowed incorporation of a variety of substituents at the R2 and R3 positions, as highlighted in Fig. 1 (see 
Supplementary Information for full synthetic schemes). Briefly, non-commercial indoles were synthesised from 
a 2-nitroaniline starting material (with the respective R1 substituent) via iodination, followed by a Sonogashira 
coupling with an alkyne (corresponding to the R2 substituent), and finally a base assisted cyclisation step. 
Manipulation of the pyrrole through the Knorr pyrrole synthesis afforded the pentyl-substituted moiety at the R3 
position. Hydrogenation of the nitroindole and subsequent condensation with the pyrrole aldehyde gave the final 
products in good yields.
The new family of perenosins reported here expands the library of perenosin derivatives. Introducing alkyl 
chains of different lengths at R2 for compounds 2 (pentyl) and 4 (propyl) allowed investigation into the effects of 
encapsulation of the binding site on the transport properties of the perenosins. Another advantage of using the R2 
position for alkylation was that other substituents, such as a CF3 group (compound 3) which has been shown to 
enhance transport capabilities38, 39, could be positioned at R1 whilst retaining the alkyl chain in the structure. R3 
was alkylated allowing investigation into the effects of optimal lipophilicity40–42, showing the differences between 
having a pentyl chain on the pyrrole rather than indole (compound 5) or on both (compound 6). As indole-NH 
groups are more acidic and hence are better hydrogen-bond donors than the pyrrole-NH groups43, 44, we have also 
Figure 1. Schematic of prodigiosin (left) and perenosin (right) showing the chemical structures of these H+/Cl− 
cotransporters as free receptors and their respective HCl complexes. Three modification positions for the perenosins 
reported in this work are highlighted R1, R2 and R3.
Figure 2. Structures of the perenosins reported in this work; 1a–e from the first generation are used for 
comparison, 2–6 are new analogues based on the same indole-pyrrole scaffold of 1, and 7–8 are based on a 
modified bis-indole scaffold.
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developed two bis-indole derivatives (7 and 8) as an alternative perenosin scaffold to potentially improve anion 
binding and its effect on transmembrane transport.
Previously, we reported the X-ray crystal structure of the HCl complex of the unsubstituted analogue 
(R1 = H) of 1a35 (Fig. 3a), here we present the X-ray structure of free perenosin 2 (Fig. 3b), see the Supplementary 
Information for the single crystal X-ray structures of compounds 1d and 4. The structure of compound 2 reveals 
the formation of an orthogonal ‘narcissistic’ dimer45–47 in the solid state via intermolecular hydrogen bonds 
between the imine nitrogen acceptor and two NH donors from pyrrole and indole.
Anion Binding Studies. Proton NMR titrations were performed in DMSO-d6/0.5% H2O, to assess the ability 
of compounds 1d and 2–8 to bind chloride, added as the tetrabutylammonium (TBA) salt, in solution. Free 
perenosins showed weak binding of the chloride anion. However, in the presence of one equivalent of HPF6, 
strong binding to chloride was observed through downfield shifts of the pyrrole-NH, indole-NH and the pro-
tonated imine-NH+. All three resonances were fitted globally to the 1:1 or 2:1 (sandwich) binding models using 
Bindfit48. Apart from 1d; the data of perenosins 2–6 are more complex and did not fit well to the 1:1 model, 
however, it can be fitted to the 2:1 binding model (see Supplementary Information) with an improvement in the 
quality of fit (covfit) by >6 times (see Table 1). The curve fitting analysis demonstrated that a 2:1 sandwich-binding 
mode for perenosins 1d and 2–6 is plausible, with the protonated receptors showing a 2:1 binding mode in the 
presence of small amounts of chloride, and a 1:1 complex at higher chloride concentrations. The 1:1 and 2:1 
binding modes are supported by the PM6 optimised structures of perenosin 2, demonstrating an octahedral 2:1 
host:guest complex (Fig. 4).
By comparing the derived association constants from the 2:1 fitting analysis for perenosins 1d and 2–6, 2 
emerged to be the best receptor for binding to chloride, with the largest K11 (and K21 for most cases but smaller 
than 3, to be discussed later), as well as the largest overall binding constant β21. The superior chloride binding 
of 2 suggests that the encapsulating effect of the binding site by pentyl chain at the R2 position can enhance the 
binding affinity for chloride. This hypothesis is further proven by the decrease in binding for 4 (with a shorter 
propyl chain, hence less encapsulating) and more significant decrease for 5 (absence of an alkyl chain at the R2 
position); whilst compound 6 exhibits improved binding compared to 5 when the pentyl chain is re-introduced at 
the R2 position. Interestingly, only compound 3 exhibits strong positive cooperativity49, where K21 is much greater 
than K1150, hence a preferential 2:1 (perenosin:chloride) complex formation occurs (see speciation ratio plots in 
Supplementary Information).
Addition of one mole equivalent of HPF6 to bis-indole perenosins 7 and 8 resulted in partial protonation of 
the imine nitrogen, approximately 20% and 10% respectively. Subsequent titration of 7 and 8 in the presence of 
HPF6 (1 mole equiv.) with tetrabutylammonium chloride induced a downfield shift of only one indole-NH (NH1 
or NH1′ shown in Fig. 3), and resulted in weaker binding to chloride compared to the indole-pyrrole perenosins. 
Although the titration isotherms of 7 and 8 can be fitted to both 1:1 and 2:1 binding modes, the derived associa-
tion constants must be viewed with caution.
It must be noted that the formation of 2:1 and 1:1 host:guest complexes during the titration binding studies 
resulted in a degree of uncertainties in the derived binding constants due to the complexity of the data. We 
acknowledge that more in-depth studies (such as solvent effects and protonation equilibrium in the same sol-
vent environment) are required to gain better understanding of the 2:1 sandwich binding and the encapsulation 
effects. However, the focus of this work is on the transport and biological activities, hence it is more suitable to 
further explore the binding properties in a separate work.
Figure 3. Single-crystal X-ray structures of (a) 1a·HCl complex (CCDC: 1441636)35 with N1···Cl, N2···Cl 
and N3···Cl distances displayed as red dashed lines with measurements (Å) in black; and (b) 2 with N1···N2′, 
N3···N2′, N1′···N2 and N3′···N2 distances displayed as red dashed lines, with measurements (Å) in black.
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pKa Studies. The pKa at which protonation of the imine (N2, see Fig. 3) occurs gives an indication of the opti-
mum pH for the binding of chloride anions. This is an important consideration in anti-cancer drug develop-
ment as the external pH environment of cancer cells is mildly acidic (pH 6.7)53 compared to that of healthy 
cells (pH 7.2–7.5)54. This can be exploited to selectively target cancer cells and potentially reduce the cytotoxic 
effects of perenosins when used as therapeutics for anti-cancer treatment. The apparent pKa values, shown in 
Table 1, for compounds 1d and 2–8 were determined both in aqueous solution (pKa (aq)) and in the presence of a 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid bilayer membrane (pKa (mem)). UV spectropho-
tometric titrations were conducted by varying the pH condition from neutral to acidic with the titration of either 
HPF6 or HCl. While the neutral perenosin has an absorbance maxima of ~380 nm for 1d and 2–6 and ~330 nm 
for 7–8, protonation resulted in a red shift to ~420 nm and ~400 nm respectively.
The apparent pKa values were derived from nonlinear curve fitting of the absorbance plotted against the pH; 
global fitting of both wavelengths corresponding to the neutral and protonated species were performed whenever 
feasible, see Supplementary Information for details. The pKa values obtained for 1d and 2–8 are lower in the 
presence of a lipid bilayer, indicating that the lipid bilayer stabilises the neutral form of the compound to some 
extent55, 56.
Transmembrane Transport Studies. Cl−/NO3− antiport at pH 7.2. The chloride transport properties of 
the new perenosins 2–8 were compared to 1d using the chloride/nitrate exchange assay monitored by a chloride 
ion selective electrode (ISE). Typically, unilamellar vesicles were prepared from POPC, containing an intravesicu-
lar NaCl solution (489 mM with 5 mM phosphate buffer at pH 7.2) suspended in a NaNO3 solution (489 mM with 
5 mM phosphate buffer at pH 7.2). All perenosins were added as a DMSO solution and the rate of chloride efflux 
was monitored by the chloride ISE. At the end of the experiment (300 s), detergent was added to lyse the vesicles 
and obtain the 100% chloride efflux reading. Dose response studies of 1d and 2–8 were performed to allow Hill 
analysis, giving the EC50 values and Hill coefficients as shown in Table 2.
Perenosin
Association constants (M−1) of Cl− in the presence of HPF6 (1 equiv.)
pKa (aq) pKa (mem)1:1 (Ka) covfita 2:1 β21b covfita
1d 605 3.3 × 10−3 K11: 1750 K21: 190 3.33 × 105 1.5 × 10−3 6.35 5.42
2c 2450 6.2 × 10−3 K11: 2500 K21: 473 1.18 × 106 1.0 × 10−3 6.08 5.85
3c 3440 6.4 × 10−2 K11: 190 K21: 2070 3.93 × 105 2.6 × 10−3 n.d.e n.d.e
4c 3440 1.1 × 10−2 K11: 1530 K21: 306 4.68 × 105 1.2 × 10−3 6.78 6.12
5c 2610 5.2 × 10−3 K11: 331 K21: 14 4.63 × 103 8.6 × 10−4 6.44 5.81
6c 78300 8.8 × 10−2 K11: 1090 K21: 158 1.72 × 105 7.5 × 10−3 n.d.e n.d.e
7d 157 1.0 × 10−2 K11: 72 K21: 507 3.65 × 104 8.2 × 10−4 5.51 5.07
8d 142 4.0 × 10−3 K11: 184 K21: 193 3.55 × 104 1.2 × 10−3 6.28 5.62
Table 1. Overview of association constants for the complexation between protonated perenosins (1d and 2–8) 
and Cl− (as TBA salt) in DMSO-d6/0.5% H2O at 298 K. aThe covariance of the fit (covfit) is calculated by dividing 
the (co) variance of the residual (experimental data − calculated data) with the covariance of the experimental 
data50. bThe overall association constant (β21) for the 2:1 host:guest complex; calculated by multiplying K11 and 
K21. cPoor fitting to the 1:1 binding model, the derived Ka is reported here for completeness and comparison of 
the covfit between 1:1 and 2:1 fitting. dPartial protonation of bis-indole perenosins 7 (~20%) and 8 (~10%), the 
derived association constants should be viewed with caution. epKa not determined due to precipitation from 
solution.
Figure 4. Theoretical (PM651) optimised structures performed using Gaussian0952 for compound 2 in both the 
1:1 and 2:1 binding mode; shown in space-filling models.
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Perenosin 1d, bearing a pentyl group at R1 position, achieved moderate transport efficiency with an EC50 
of 0.122 mol%. On the other hand compound 2, with pentyl substitution at R2 position, has a remarkable EC50 
value of 0.0043 mol% being the most effective transporter of the entire series, and is comparable to the natural 
product and synthetic analogues of tambjamines39. However, introduction of the pentyl group at the R3 position 
in compound 5 decreased the transport capabilities as compared to compound 2 (but the compound still per-
formed better than 1d), with an EC50 value of 0.0227 mol%. While perenosins 1d, 2 and 5 all possess a pentyl 
chain at R1, R2 or R3 positions with very similar log P values (4.9–5.3), the respective transport efficacies are 
significantly different. This outcome highlights the beneficial effect of strategically positioning the pentyl chain to 
improve the mobility within the lipid bilayer and more importantly, enhancing the encapsulation of the binding 
site. Compound 3 achieved a maximum chloride efflux of 35% (after 300 s) at a high loading of 10 mol%, so an 
EC50 value could not be determined; this is likely due to poor solubility in aqueous solution as was observed in 
the pKa studies. Compound 4 bearing a shorter propyl group at R2 position resulted in a slightly poorer EC50 of 
0.0111 mol% c.f. 2, which can be attributed to the lower lipophilicity and lesser encapsulating effect by the shorter 
alkyl chain. The most lipophilic compound 6, with two pentyl groups at the R2 and R3 positions, resulted in a 
decrease of transport capabilities with an EC50 of 0.0852 mol% and this is presumably due to the compound’s 
unfavourably high lipophilicity and poor solubility. Finally, compounds 7–8 gave weak transport activity at pH 
7.2 and Hill analysis could not be used to calculate EC50, potentially due to a number of factors; (1) the pKa values 
being two pH units lower than the pH condition of the experiment for compound 7, (2) weak chloride binding 
and (3) unfavourably high lipophilicity. Overall, the new perenosins bearing the indole-pyrrole scaffold achieved 
better transport efficiencies than 1d, the best perenosin transporter previously reported.
pH dependent Cl−/NO3− antiport. The external pH of cancer cells (pH 6.753) is slightly acidic compared to 
healthy cells (pH 7.2–7.554). Therefore, for the perenosins to show a degree of cytotoxic selectivity towards can-
cer cells over healthy cells it is desirable for cellular HCl cotransport to be more effective in the mildly acidic 
cancerous cell environment. To investigate the effect of pH on the chloride transport capabilities unilamellar 
vesicles were loaded with NaCl (489 mM) and suspended in NaNO3 (489 mM), and the internal and exter-
nal solutions were buffered to pH 4.5, 6.5, 7.2 and 10 using various buffers (more detail can be found in the 
Supplementary Information). Compounds 1d and 2–8 were then tested in a single point screen at 0.1 mol% load-
ing (Fig. 5). At pH 4.5 the perenosins exist predominantly as the active protonated species and so all compounds 
show moderate to high chloride transport properties, whereas, there is no chloride transport observed at pH 
10 (see Supplementary Information for results). For all compounds, except 7, an increase in chloride transport 
is observed at pH 6.5 compared to pH 7.2, suggesting that these perenosins could potentially be more selective 
toward cancer cells (Fig. 6).
H+/Cl− symport mechanism studies. The previously reported perenosins 1a–e were shown to function in the 
same way as prodigiosin and facilitate chloride transport when protonated through H+/Cl− symport (see Fig. 1), 
as demonstrated using a HPTS liposome-based assay20, 35. Herein, we employed two recently reported comple-
mentary cationophore coupled assays19 to unambiguously confirm H+/Cl− symport facilitated by perenosins is a 
strictly inseparable process. Briefly, unilamellar vesicles were prepared with an internal solution of KCl (300 mM) 
and an external solution of K2SO4 (150 mM), buffered to pH 7.2 with potassium phosphate salts (5 mM). The 
Perenosin clog Pa
Cl−/NO3− at pH 7.2 (by ISE) NMDG-Cl (by HPTS)
EC50 (mol%)b nc
EC50 
(mol%)d
EC50 (Gra) 
(mol%)e
EC50 (OA) 
(mol%)f SGg FOAh
1d 5.1 0.1220 1.2 0.01073 0.00656 0.00925 1.6 1.2
2 4.9 0.0043 1.3 0.00062 0.00037 0.00085 1.7 0.7
3 5.7 n.d.i n.d.i 0.01151 0.00879 0.04912 1.3 0.2
4 4.4 0.0111 1.1 0.00069 0.00038 0.00008 1.8 8.6
5 5.3 0.0227 1.3 0.00231 0.00095 0.00273 2.4 0.9
6 6.9 0.0852 0.3 0.00249 0.00211 0.00208 1.2 1.2
7 6.1 >10j n/aj n.d.j n.d.j n.d.j n/aj n/aj
8 6.2 >10j n/aj n.d.j n.d.j n.d.j n/aj n/aj
Table 2. EC50 values shown for the Cl−/NO3− antiport assay, the NMDG-Cl assay alone, with gramicidin 
(Gra) and with oleic acid (OA), with the chloride selectivity (SG) and the factor of enhancement (FOA) included. 
aaverage clog P values calculated using VCCLab62. bEC50 at 270 s, shown as carrier: lipid molar percent. cHill 
coefficient reveals the stoichiometry of the complex mediating transport. dEC50 from the NMDG-Cl assay, 
measuring H+/Cl− symport. eEC50 in the presence of Gra, showing the total H+/Cl− symport possible with no 
rate limiting H+/OH− transport. Gra concentration has been optimised to 0.1 mol%. fEC50 in the presence of 
OA, showing changes in transport due to acceleration of the natural proton transport facilitated by fatty acids. 
OA concentration has been optimised to 2 mol%. gSG > 1 indicates Cl− selectivity and is calculated by dividing 
EC50 in absence of Gra by EC50 (Gra). hFactor of enhancement in the overall H+/Cl− cotransport rate is calculated 
by dividing EC50 in absence of Gra or OA by EC50 (OA). FOA > 1 suggests the receptor can assist the flip-flop of 
OA− increasing pH dissipation. in.d. EC50 not determined by ISE due to poor solubility. jWeak transport ability 
where EC50 for Cl−/NO3− by ISE is larger than 10 mol%, hence NMDG-Cl by HPTS assay not determined (n.d.).
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naturally occurring cationophores valinomycin and monensin were either added alone, or in combination with 
a perenosin and the resulting chloride efflux, driven by a large chloride concentration gradient, was monitored 
using a chloride ISE. Valinomycin is selective for K+ and facilitates electrogenic transport which results in a net 
flow of charge across a lipid membrane, however, this does not directly affect the transmembrane pH gradient57. 
In contrast, monensin functions as an electroneutral transporter. Deprotonation of a carboxylic acid group occurs 
upon metal complexation allowing M+/H+ antiport (exchange) which results in an intra-vesicular pH change 
(illustrated in Fig. 6)58.
Compounds 1d and 2–6 were tested in the cationophore coupled assays and, in all cases, chloride efflux was 
observed when coupled to monensin and only a very small amount, <5%, of chloride efflux occurred in the pres-
ence of valinomycin. The K+/H+ antiport facilitated by monensin is coupled to the H+/Cl− cotransport facilitated 
by the receptors resulting in the overall KCl efflux observed. Therefore, the perenosins function as strict insepa-
rable H+/Cl− cotransporters and display the same mechanism as prodigiosin, requiring protonation of the free 
imine-N2 to facilitate anion transport. The protonated perenosins cannot back-diffuse into the liposome resulting 
in the ‘strict’ HCl co-transport.
Selectivity mechanism studies. The selectivity for Cl−>H+/OH− transport of the perenosins was quantified using 
a modified NMDG-Cl assay18. Unilamellar vesicles loaded with HPTS (1 mM) and N-methyl-D-glucamine chlo-
ride (NMDG-Cl) (100 mM), buffered to pH 7 with HEPES (10 mM) were prepared. Free base NMDG (0.5 M) was 
added increasing the extravesicular solution to pH 8, and the dissipation of this gradient following the addition 
of receptors was monitored. Dissipation of pH gradient indicates H+/Cl− symport (or the functionally equivalent 
OH−/Cl− exchange) mediated by perenosins. Gramicidin D (Gra) is a proton channel added to facilitate H+ 
transport. The addition of oleic acid (OA), a naturally occurring fatty acid found in cell membranes, allowed the 
investigation of the enhancement in H+/Cl− symport, in the presence of oleic acid. Anion transporters can assist 
the fatty acid flip-flop mechanism by taking on the role of a flippase for fatty acid anions via binding to the ani-
onic carboxylate head group, masking the charge and allowing rapid passage of the head group through the lipid 
bilayer. This in turn accelerates the natural proton transport mediated by fatty acids in biological membranes59.
For all cases EC50 values were obtained from dose-response experiments and subsequent Hill analysis (see 
Supplementary Information). Chloride selectivity was then quantified to give a selectivity factor (SG), shown in 
Table 2, using the ratio of the EC50 values. From the previous cationophore coupled assays, it was evident that the 
capability of perenosins to facilitate electrogenic chloride transport is negligible, therefore an absence in selectiv-
ity for Cl−>H+/OH− was expected. The selectivity for chloride (SG) is calculated by dividing EC50 in absence of 
Gra by EC50 (Gra), and the SG factors obtained for compounds 1d and 2–6 are all marginally greater than one which 
indicates a minor increase in the rate of transport in the presence of Gra, attributed to a small degree of Cl−>H+/
OH− selectivity. Factor of enhancement (FOA) in the overall H+/Cl− cotransport rate facilitated by OA is calcu-
lated by dividing EC50 in absence of Gra or OA by EC50 (OA), a value greater than one suggests the receptor can 
assist the flip-flop of OA− increasing pH dissipation. FOA values for the overall H+/Cl− cotransport rate were cal-
culated for compounds 1d and 2–6 in the presence of OA and are also shown in Table 2. Interestingly, compound 
4 has a FOA value of 8.6, indicating a significant increase in the overall transport rate in the presence of fatty acids. 
This suggests that the receptor coupled fatty acid flip-flop is enhancing the overall rate of H+/Cl− cotransport (or 
OH−/Cl− exchange). This acceleration in transport rate also suggests that the rate limiting step in the NMDG-Cl 
assay for compound 4 is the back-diffusion of the neutral transporter across the lipid bilayer, due to the lower log 
P value. In the presence of fatty acids, an alternative pathway that involves the diffusion of the fatty acid complex 
and free fatty acids could replace this step. Conversely, compounds 2, 3 and 5 have FOA values lower than one, 
indicating slower H+/Cl− symport rate in the presence of fatty acids. This may be likely due to the competitive 
binding of the receptors to the carboxylate head group so inhibiting chloride binding and transport.
Figure 5. Chloride efflux achieved from compounds 1d and 2–8 at 0.1 mol% loading from unilamellar vesicles 
loaded with NaCl (489 mM) suspended in NaNO3 (489 mM) buffered to pH 6.5 (left) and pH 7.2 (right) with 
sodium phosphate salts (5 mM). All data are the average of three repeats, performed using the same batch of 
vesicles, with error bars corresponding to the SD.
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Other mechanistic studies. To further probe other aspects of transmembrane transport mechanism of perenos-
ins, a variety of studies were employed. A Cl−/NO3− antiport assay using an ISE method, as described previously 
in Cl−/NO3− antiport at pH 7.2, was performed in POPC:cholesterol (7:3) vesicles; the addition of cholesterol 
decreases the fluidity and permeability of the membrane60 and this resulted in a lower percentage efflux facilitated 
by perenosins 1d and 2–8 compared to the same assay done in POPC vesicles. Sulfate is a highly hydrophilic, 
strongly hydrated anion that is difficult to transport over lipid bilayers61; using the Cl−/NO3− antiport assay and 
changing the external solution to Na2SO4 from NaNO3 showed no Cl− efflux upon addition of 1d and 2–8, indi-
cating that sulfate transport is not facilitated by the perenosins. Using the same conditions for sulfate transport, 
and adding a bicarbonate pulse at 120 s to give a final external bicarbonate concentration of 40 mM, allowed 
observation of potential Cl−/HCO3− antiport elicited by 1d and 2–8; no Cl− efflux was detected, presumably 
due to the basicity of bicarbonate anion preventing protonation of the imine-N2. Finally, preincorporation of 
1d and 2–6 into POPC vesicles followed by performing a similar NMDG-Cl assay, and subsequent dilution of 
the resulting lipid solution, investigated how perenosins behave in a lipid membrane environment. The H+/Cl− 
cotransport rates at different lipid concentrations remained unchanged, indicating that the perenosins remained 
in the lipid bilayer over the course of the transport experiments rather than partitioning into the aqueous phase. 
See Supplementary Information for more details of results and experimental details of these assays.
In Vitro Studies. Cell viability studies. Preliminary cell viability studies on the first generation perenosins 
conducted at the University of Southampton suggested cytotoxic selectivity for cancerous cells (MDA-MB-231 
and MCF-7) over non-cancerous cells (MCF-10A)35. Herein, we carried out further in vitro studies at the 
University of Barcelona for the full library of perenosins. Single dose screening for cell viability using the meth-
ylthiazoletetrazolium (MTT) colorimetric assay over five different cell lines (cancer cells MCF-7, MDA-MB-231, 
A549 and SW620, and non-cancerous human cells MCF-10A) was conducted. After exposure to the perenosins 
(10 µM) for 24 h, interestingly, all perenosins exhibited selective cell viability decrease in human breast adenocar-
cinoma cell line (MDA-MB-231) over the other cell lines (see Supplementary Information).
Encouraged by these single dose screening results, dose response MTT assays were performed for the first 
time with compounds 2–8 and repeated for compounds 1a–e, on MDA-MB-231 cells to obtain IC50 values (inhib-
itory concentration of 50% of cell population) systematically at 24 h and 72 h incubation periods, see Table 3. 
Among compounds 1a–1e, 1d (being the best transporter in liposome studies) is the most potent after 24 h expo-
sure time. Additionally, perenosin 1d remains the most potent compound after 72 h exposure time, and there 
is a slight decrease in cell viability by a factor of 1.2–1.7 for all the first generation of perenosins. Interestingly, 
compounds 2–8 exhibited an apparent structure-activity relationship for the onset of cytotoxic effect. There is 
negligible effect in cell viability (IC50 > 100 µM) after 24 h incubation time for perenosins with alkyl substituents 
at R2 (2–4, 6 and 8). However, there is a significant late onset of affecting the cell viability after 72 h, with 6 being 
the most potent perenosin (IC50 (72 h): 4.2 µM) in MDA-MB-231 cells. While perenosin 5, with pentyl substituent 
at R3, has similar cell viability effects as 1d, bis-indole perenosin 7 with pentyl substituent at R1 has a moderate 
degree of late onset by a factor of 7.
Figure 6. Schematic of the cationophore coupled KCl efflux assays measured by chloride ISE, from 
unilamellar POPC vesicles loaded with KCl (300 mM) and suspended in K2SO4 (150 mM), buffered to pH 7.2 
with potassium phosphate salts (5 mM). (a) Overall KCl efflux induced from a combination of electrogenic 
K+ transport facilitated by valinomycin (Vln) (0.1 mol%) and electrogenic Cl− transport facilitated by the 
transporter (T). (b) Overall KCl efflux induced from electroneutral transport processes; K+/H+ antiport 
by monensin (Mon) (0.1 mol%), and Cl−/H+ symport and Cl−/H+ antiport facilitated by transporter (T). 
(c) Chloride efflux facilitated by compound 2 (0.1 mol%). (d) Chloride efflux facilitated by prodigiosin 
(0.01 mol%). All data are the average of three repeats, performed using the same batch of vesicles, with error 
bars corresponding to the SD.
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Cell-death mechanism studies. The specific late onset of affecting cell viability induced by perenosins is inter-
esting, and to the best of our knowledge this phenomenon has not been observed for other anion transporters. 
Furthermore, this is governed by the unique structure-activity relationship displayed when bearing alkyl substitu-
ents at the R2 position (2–4, 6 and 8). However, the apparent potency (IC50) of these perenosins from the MTT assay 
does not correlate well with the anion transport efficacy from liposome-based studies. To investigate this further, 
Annexin-V was used as a marker with flow cytometry analysis to evaluate apoptosis in MDA-MB-231 cells after 
treatments with 2 (best transporter) and 6 (most potent) at their respective IC50 values. It is known that synthetic 
transporters can disrupt ion homeostasis in cells and induce cell death via an apoptotic pathway3, 22, 32, 63, 64.
As shown in Fig. 7 (see Supplementary Information for details), perenosin 2 clearly induces cell death by 
apoptosis, with a higher population of early apoptotic cells after 48 h exposure time and then transitioning to 
greater proportion of cells in late apoptosis after 72 h. Unexpectedly, the most potent perenosin 6 (from MTT 
cell viability assay) resulted in slight increase in apoptotic cells at the IC50 value after 48 h and 72 h. To confirm 6 
induces apoptosis in cells, a higher concentration dose of 6 (10 µM) was used and demonstrated an increase in 
both early and late apoptotic cell populations. From this Annexin-V assay, we conclude that the best transporter 
2 is more cytotoxic in inducing cell apoptosis, in contrast to the most potent compound 6 from the MTT assay. 
Therefore, the IC50 value of compound 6 obtained from MTT cell viability studies may be due to a combination 
of cell cycle arrest and apoptosis. This also suggests that other cellular effects can be induced by 6 such as DNA 
intercalation which disturbs the normal cell cycle, and not solely disruption of ion homeostasis. It should be 
mentioned that perenosins hydrolyse steadily (as shown in our preliminary investigation in aqueous buffer (see 
Supplementary Information)), due to the presence of the imine moiety.
Conclusions
The design of anion transporters often involves having a suitable alkyl chain to achieve optimal log P; however, we 
have also demonstrated the importance of positioning the alkyl chains to significantly enhance the anion binding 
Perenosin IC50 (24 h) IC50 (72 h) FAa Perenosin IC50 (24 h) IC50 (72 h) FAa
1a 38.3 (1.6) 24.4 (0.5) 1.6 2 >100b 11.3 (0.8) n/ab
1b 32.2 (1.9) 22.1 (2.7) 1.5 3 >100b 9.5 (0.1) n/ab
1c 34.4 (1.7) 20.4 (0.3) 1.7 4 >100b 9.2 (2.2) n/ab
1d 25.2 (4.0) 16.6 (0.7) 1.5 5 20.3 (0.5) 14.0 (0.3) 1.5
1e 38.4 (8.5) 32.7 (3.0) 1.2 6 >100b 4.2 (1.6) n/ab
7 73.8 (6.5) 11.0 (2.1) 6.7
8 >100b 38.0 (1.9) n/ab
Table 3. IC50 values (µM, with error from three repeats in brackets) of first and second generations of 
perenosins 1a–e and 2–8 on the human breast adenocarcinoma (MDA-MCB-231) cell line with 24 h and 
72 h exposure time. aFactor of activity (FA) enhancement between 24 h and 72 h exposure time, IC50 (24 h) 
divided IC50 (72 h). bEffect of cell viability is too weak (>100 µM) for IC50 dose response determination, hence 
factor of activity enhancement not applicable (n/a). Differences in IC50 values were observed between results 
of experiments reported previously from the University of Southampton and those reported here from the 
University of Barcelona, with a systematic error of ~20 µM. Whilst reason for these differences is unclear, it is 
important to note that the IC50 values reported here display the same trend as those previously reported35.
Figure 7. Results of Annexin-V flow cytometric assay on MDA-MB-231 cells, showing the distributions of cells 
present in the early and late apoptotic populations when treated with IC50 values of perenosins 2 (left) (11 µM) 
and 6 (right) (4 µM).
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and transport properties of the perenosins. While perenosin 1d emerged as the best compound from the original 
report (EC50 (ISE) 0.122 mol% and (HPTS) 0.0107 mol%), compound 2 shows a remarkable enhancement in 
the transmembrane anion transport (EC50 (ISE) 0.0043 mol% and (HPTS) 0.00062 mol%). This was achieved by 
changing the pentyl chain from position R1 to R2, to introduce the encapsulation/dehydration effects of the anion 
binding site by an alkyl chain. By using the cationophore-coupled ISE and gramicidin-coupled HPTS assays, the 
perenosins have been confirmed to function predominantly by the electroneutral mechanism of strictly insepa-
rable H+/Cl− symport, in a similar fashion to prodigiosin. Additionally, the Cl−>H+/OH− selectivity as well as 
their transport capabilities in the presence of fatty acids have been investigated.
In vitro studies of our full library of perenosins demonstrated a decrease in cell viability of the human breast 
adenocarcinoma (MDA-MB-231) cell line over other non-cancerous and cancer cells. More interestingly, the new 
perenosins (2–4, 6 and 8) bearing an alkyl substituent at the R2 position serendipitously exhibited a distinctive 
late onset of cytotoxicity effect observed between 24 h and 72 h from the cell viability studies using MTT assays. 
Additionally, the cell death mechanism was evaluated using Annexin-V assays to confirm the apoptotic pathway 
as well as possible cell cycle arrest mechanism. The excellent anion transport efficacy in liposomes and cytotox-
icity observed towards human breast adenocarcinoma cells demonstrated that the perenosins are potentially 
suitable candidates as anticancer therapeutics.
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